Phase 1 Fanconi Anemia Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

Fanconi Anemia

Porteus, Matthew, MD18 enrolled1 locationNCT04784052

Recruiting

Phase 1Phase 2

Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Head and Neck Squamous Cell CarcinomaFanconi Anemia

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau25 enrolled2 locationsNCT06648096